Close
Close

Pharma’s French Conundrum

After nearly a decade of the French government trying to steadily decrease the price of drugs, it goes without saying that Emmanuel Macron’s pro-business program was eagerly anticipated by the pharmaceutical industry....
Read More

To Build Trust, Address Price

Providers’ views on the relationship between price and value in building patient trust....
Read More

Patient Engagement: The New Normal

Today more than ever, pharmaceutical companies are increasingly dependent on collaboration with patients. ...
Read More
Loading

Notice

APCO Forum blog posts represent the voice of the author and not necessarily the corporate position or policy of APCO Worldwide.
Close